Jim Simons’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-239,700
Closed -$4.59M 3806
2024
Q3
$4.59M Buy
239,700
+185,600
+343% +$3.85M 0.01% 1501
2024
Q2
$1.12M Buy
+54,100
New +$1.08M ﹤0.01% 2260
2023
Q4
Sell
-45,637
Closed -$792K 4013
2023
Q3
$792K Sell
45,637
-279,863
-86% -$5.84M ﹤0.01% 2458
2023
Q2
$6.77M Sell
325,500
-153,000
-32% -$3.33M 0.01% 1244
2023
Q1
$11.3M Buy
478,500
+20,900
+5% +$561K 0.01% 1033
2022
Q4
$12.8M Sell
457,600
-403,000
-47% -$10.3M 0.02% 957
2022
Q3
$20.1M Sell
860,600
-56,245
-6% -$1.7M 0.03% 669
2022
Q2
$30.9M Buy
916,845
+167,660
+22% +$5.87M 0.04% 525
2022
Q1
$26.2M Buy
749,185
+561,200
+299% +$19.2M 0.03% 616
2021
Q4
$5.72M Buy
+187,985
New +$6.12M 0.01% 1447

Other funds holding OGN

Jim Simons's OGN Position: Q4 2024 in Review

Jim Simons sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 239,700 shares — an estimated $4.59M sold.

Jim Simons first reported a position in OGN in Q4 2021 and held it in 10 quarters. The position peaked at $30.9M in Q2 2022. 739 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Jim Simons reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Jim Simons sold 239,700 Organon & Co shares in Q4 2024, an estimated $4.59M.
  • Jim Simons first reported a position in Organon & Co in Q4 2021 and held it in 10 quarters.
  • Jim Simons's Organon & Co position peaked at $30.9M in Q2 2022.
  • 739 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.